About The Tisch Cancer Institute

With vision, commitment, and exceptional expertise, The Tisch Cancer Institute at Mount Sinai Medical Center is emerging as an innovative leader in patient care and research. Through a range of multidisciplinary programs spanning prevention, detection, and treatment, the Institute builds on Mount Sinai’s extraordinary history of medical breakthroughs to offer new hope for those living with or at risk of cancer. 

The Tisch Cancer Institute extends Mount Sinai’s leadership in the practical application of cutting-edge research, providing patients with access to the most current and promising treatments and techniques available. The Institute also plans and participates in clinical trials, which qualified individuals may enroll in for the benefit of patients now and in the future. 

Our Mission 

Our mission is to build upon Mount Sinai Medical Center’s reputation for excellence in research and clinical care to find new ways to prevent, treat, and cure cancer. The Tisch Cancer Institute has access to levels of research expertise and patient care that few other cancer centers can offer. 

Our Future 

The Tisch Cancer Institute has made a formidable impact on cancer care and research at Mount Sinai and is a prominent presence on the Mount Sinai campus. Because the Institute spans a number of different departments, divisions, and centers, our robust clinical and research programs are located in buildings throughout the Mount Sinai campus. Cancer patients receive comprehensive outpatient care at the Derald H. Ruttenberg Treatment Center, as well as personalized inpatient care at Mount Sinai Hospital. 

As The Tisch Cancer Institute continues to grow, we will implement new multidisciplinary programs and construct new buildings for patient care and scientific research. Nearly one-third of Mount Sinai’s strategic investments have been dedicated to cancer care and research — illustratrating Mount Sinai’s commitment to fighting the disease. 

Additional services include screening, clinical trials, genetic counseling, psychosocial support, nutritional counseling, complementary medicine, and wellness counseling . 

The Tisch Cancer Institute will also occupy four full floors of Mount Sinai’s planned translational research facility, the Center for Science and Medicine (CSM): two floors for basic research and two for clinical care and research. 

The Derald H. Ruttenberg Treatment Center will more than double in clinical capacity when it moves into the CSM. CSM construction began in 2008, and is scheduled to be completed in 2012.

The Dubin Breast Care Center, a 15,000 square foot facility located on the first floor of the Klingenstein Pavilion, opened in 2011. The Center represents a bold new vision for breast cancer care and research — one that focuses on the physical and emotional health of individuals with or at risk for breast cancer. The Dubin Center houses a range of multidisciplinary services in one centralized location.